Last reviewed · How we verify

NCT05878197

Effect of Semi-occluded Vocal Tract Therapy on the Phonation of Children With Vocal Fold Nodules

Completed NA Results posted Last updated 10 October 2024
What this trial tests

NA trial testing Straw phonation in Voice Disorders in Children in 30 participants. Completed in 3 April 2023.

Timeline
29 July 2019
Primary endpoint
3 April 2023
3 April 2023

Quick facts

Lead sponsorUniversity Hospital, Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date29 July 2019
Primary completion3 April 2023
Estimated completion3 April 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

Adults 6 to 12, any sex, with Voice Disorders in Children or Vocal Nodules in Children. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Dysphonia Severity Index Primary · pre: one day before therapy, day 0; post: immediately after last therapy session, day 4

The dysphonia severity index (DSI) is a multiparametric score to quantify vocal capabilities. It is based on a weighted combination of 4 voice parameters: maximum phonation time (MPT, s), highest frequency (F-high, Hz), lowest intensity (I-low, dB) and jitter (%). The DSI is constructed as 0.13 MPT + 0.0053 F-high - 0.26 I-low - 1.18 jitter +12.4. The index ranges from -5 to +5. A score above +1.6 is considered normal. A higher score corresponds with better voice quality / vocal capacities.

GroupValue95% CI
Experimental Group 1 - Straw Phonation1.80.1 – 3.4
Experimental Group 2 - Resonant Voice Therapy1.80.1 – 3.4
Control Group0.0-1.9 – 1.9
Change in Acoustic Voice Quality Index Primary · pre: one day before therapy, day 0; post: immediately after last therapy session, day 4

The acoustic voice quality index (AVQI) is a multiparametric score to quantify vocal quality. It is based on a weighted combination of 6 voice parameters: smoothed cepstral peak prominence (CPPS), harmonics-to-noise ratio (HNR), shimmer local (SL), shimmer local dB (SLdB), general slope of the spectrum (slope) and tilt of the regression line through the spectrum (tilt). The formula is constructed as 9.072 - 0.245 × CPPs - 0.161 × HNR - 0.470 × SL + 6.158 × SLdB - 0.071 × Slope - 0.170 × Tilt and ranges from 0 to 10. A lower score correlates with a better vocal quality.

GroupValue95% CI
Experimental Group 1 - Straw Phonation-0.1-0.6 – 0.4
Experimental Group 2 - Resonant Voice Therapy-0.4-1.1 – 0.3
Control Group-0.3-0.9 – 0.3
Change in Pediatric Voice Handicap Index (pVHI) Primary · pre: one day before therapy, day 0; post: immediately after last therapy session, day 4

The pediatric voice handicap index (pVHI) is a questionnaire to investigate children's voice-related quality of life, completed by the parents. The index ranges from 0 to 92. A higher score correlates with more psychosocial impact of the voice disorder.

GroupValue95% CI
Experimental Group 1 - Straw Phonation-3.3-7.2 – 0.7
Experimental Group 2 - Resonant Voice Therapy-3.9-8.3 – 0.4
Control Group-1.7-6.7 – 3.2
Change in Overall Severity From Consensus Auditory-Perceptual Evaluation of Voice Primary · pre: one day before therapy, day 0; post: immediately after last therapy session, day 4

This tool is designed to describe the severity of dysphonia by rating six parameters (overall severity, roughness, breathiness, strain, pitch, and loudness) on a visual-analog scale from 0 to 100, where 0 is considered within normal limits. A higher score corresponds with worse voice quality.

GroupValue95% CI
Experimental Group 1 - Straw Phonation-6.5-12.2 – -0.9
Experimental Group 2 - Resonant Voice Therapy-0.7-6.4 – 4.9
Control Group-1.0-7.7 – 5.7

Sponsor's own description

The goal of this clinical trial is to determine and compare the effects of different voice therapy programs in children with vocal fold nodules. Vocal fold nodules are non-cancerous growths on the vocal folds which cause hoarseness. The main questions this trial aims to answer are: * What are the short-term effects of the new voice therapy program 'straw phonation' and a more traditional 'resonant voice therapy' program on (a) the vocal quality, (b) the size of the growths on the vocal folds, and (c) the overall functioning in children with vocal fold nodules? During straw phonation exercises, you make sound through a drinking straw. During resonant voice therapy exercises or 'humming', you make an 'm' sound as you breathe out. * What are the long-term effects of these voice therapy programs? Participants will receive a short-term intensive voice therapy program of four days. The researchers will compare the straw phonation group, resonant voice therapy group and control group to see if voice therapy works well in treating children with vocal fold nodules. The researchers hypothesize that straw phonation will have better results than resonant voice therapy. Straw phonation exercises are easier for children because they use an external tool (the straw) and less self-correction is needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05878197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing